Kuros Biosurgery Holding Ltd. has closed the merger with Cytos Biotechnology Ltd. which is renamed Kuros Biosciences Ltd. Starting 20 January 2016 all Kuros Biosciences Ltd. shares are listed and freely tradable under the ticker symbol KURN on the SIX Swiss Exchange.
Swisscon and Open Web Technology are merging their digital competencies. As a result of the transaction the two companies will form a joint venture establishing a leading provider of digital transformation consulting services for large companies in Switzerland.
NBE-Therapeutics and the group of Prof. Zaborosch at Zurich School of Applied Sciences (ZHAW), Wädenswil, have announced the award of a CHF 1.1 Mio grant from the Swiss Commission for Technology and Innovation (CTI) for their joint project.